Requests
Answer the business quickly
Take requests from R&D, supply chain and commercial teams and get a first review of each CDA or agreement back.
Pharma and life sciences
Review trial, supply, distribution and licensing agreements against your own playbook,
and answer regulatory questions from sources your team can check.
The challenge
Pharma and life sciences legal teams handle clinical trial agreements with sites and CROs, confidentiality agreements, CDMO quality and supply agreements, loan licence arrangements, C&F agent, stockist and distributor agreements, in- and out-licensing and KOL consultancy agreements, under the Drugs and Cosmetics Act 1940, the New Drugs and Clinical Trials Rules 2019, the Medical Devices Rules 2017, UCPMP 2024, DPCO 2013 and the Patents Act 1970.
What was agreed with a distributor or a CRO sits in signed PDFs and amendments that nobody has time to reread.
Distributor networks and trial sites run to hundreds of agreements, each a little different.
Price control, marketing practice and trial rules shape terms across supply, marketing and research.
Requests
Take requests from R&D, supply chain and commercial teams and get a first review of each CDA or agreement back.
Visibility
See open agreements, regulatory queries and disputes across the team, with what is due and who has it.
Consistency
Check CTAs, supply and distribution agreements against your positions, including DPCO price revision and NDCT Rules 2019 trial compensation terms, and get each deviation with a fallback.
Standards
Apply the same positions on indemnity, publication and IP, whoever on the team runs the review.
One workspace for the agreements, regulation and disputes across research, supply and sales.
Review CTAs, CDAs, supply, distribution and licensing agreements against your playbook, with deviations flagged and fallbacks suggested.
Ask one question across an agreement and all its amendments, or hundreds of distributor contracts: territory, price revision, termination and indemnity.
Answers on the NDCT Rules 2019, UCPMP 2024, DPCO 2013, the Medical Devices Rules 2017 and the Patents Act 1970, with every citation one click from its source.
CDAs, consultancy agreements and distributor agreements in your own format, inside Word or the web app.
Translate regional-language notices, orders and records with legal terms kept precise.
Lexi for pharma and life sciences legal teams in India is one workspace for drug makers, CDMOs, CROs and device companies to review trial, supply, distribution and licensing agreements against their own playbook, ask questions across agreements and amendments, draft from their templates and research NDCT Rules, UCPMP and patent questions with citations.
Yes. Lexi reads the CTA against your playbook, flags the indemnity, publication, IP and payment terms that depart from your positions, and suggests a fallback.
Lexi researches the Drugs and Cosmetics Act 1940, the New Drugs and Clinical Trials Rules 2019, the Medical Devices Rules 2017, UCPMP 2024, DPCO 2013 and the Patents Act 1970, with citations to the rules and judgments your team can check.
Yes. Lexi is ISO 27001 and ISO 42001 certified, and SOC 2, GDPR and DPDP compliant, with SSO and SAML for your team. Your data is never used to train Lexi’s models, and your documents stay private to your team.
Yes. Lexi works inside Microsoft Word through its add-in, so you can review, redline and draft from your own templates without leaving the document. The same work is available in the web app, the mobile app and on WhatsApp.
See Lexi compared with Draftwise and the comparison page. For the wider in-house workflow, see Lexi for in-house legal, or the pages for defence and aerospace and SaaS.

See Lexi in action
See how Lexi brings agreements, regulatory research and disputes into one workspace. Book a personalised demo built around your team.
Book a demo